[ET Net News Agency, 14 August 2019] China Grand Pharmaceutical and Healthcare Holdings
Limited (00512) said its profit attributable to owners of the company was HK$546.96
million for the six months ended 30 June 2019, a year-on-year increase of 73.4%. The
earnings per share were HK17.22 cents. No dividend will be distributed.
The revenue was HK$3.59 billion, a year-on-year increase of 10.85%. The gross profit was
HK$2.27 billion, a year-on-year increase of 21.7%. (RC)